Startups
Cerba Research is the merge of Barc Lab, Histalim and Cerba Xpert. All 3 entities are part of the Cerba HealthCare group and have decided to join forces under one name.
Cerba Research provides the highest quality specialized laboratory and diagnostic solutions while leveraging patient data and scientific insight to shape and advance clinical trials. With our global footprint and access to leading regional labs, data, patients, technology, and partnered resources, we support global biotech, pharma, and IVD organizations to improve the lives of patients around the world.
From the translation of preclinical to clinical, through commercialization, our expert scientists collaborate with you to optimize your therapeutic development and obtain critical insights earlier. We help accelerate your therapies through the development of highly specialized custom assays, deep biomarker expertise, and a passion for scientific innovation across complex therapeutic areas. Our global network of leading, specialty laboratories ensures you have access to quality data and can reach your patients. Together, we’ll improve patients’ lives around the globe.
Cerba Research provides the highest quality specialized laboratory and diagnostic solutions while leveraging patient data and scientific insight to shape and advance clinical trials. With our global footprint and access to leading regional labs, data, patients, technology, and partnered resources, we support global biotech, pharma, and IVD organizations to improve the lives of patients around the world.
From the translation of preclinical to clinical, through commercialization, our expert scientists collaborate with you to optimize your therapeutic development and obtain critical insights earlier. We help accelerate your therapies through the development of highly specialized custom assays, deep biomarker expertise, and a passion for scientific innovation across complex therapeutic areas. Our global network of leading, specialty laboratories ensures you have access to quality data and can reach your patients. Together, we’ll improve patients’ lives around the globe.
Overview
Location
Belgium, East Flanders, Zwijnaarde
Employees
1001-5000
Phone
+32 9 329 23 29
Founded date
1984
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 23, 2024 | Element Biosciences: Over $277 Million In Series D Raised For Democratizing Access To Advanced Biological Tools | Element Biosciences, a developer of pioneering technologies to empower science, announced over $277 million in Series D funding to support its growing global customer base with disruptive DNA sequencing and multi-omics technologies for year... |
| Mar 25, 2024 | Advancing CAR T-Cell Therapies with Clinical Trial Customization, Upcoming Webinar Hosted by Xtalks | www.cerbaresearch.com In this free webinar, learn how to successfully set up and manage highly customized CAR T-cell therapy clinical trials. Attendees will learn about flow cytometry's crucial role in monitoring CAR T cells in clinical tri... |
| Oct 20, 2022 | Cerba and Taliaz to Leverage Artificial Intelligence and Genetics Expertise to Improve Patient Care Management in Depression | Cerba, the foremost specialty clinical pathology reference, and Taliaz, an Israeli digital health company dedicated to improving mental health disorders, announced a partnership to provide physicians with an AI-driven precision psychiatry s... |
| May 10, 2022 | The Added Value of Flow Cytometry in CAR T-Cell Clinical Trials, Upcoming Webinar Hosted by Xtalks | Immunophenotyping of CAR T cells by flow cytometry has provided valuable information to clinicians which helps to further improve the CAR T-cell therapy. TORONTO (PRWEB) May 10, 2022 An increasing number of clinical trials show a successful... |
| Dec 16, 2021 | Cerba Healthcare to Acquire Viroclinics-DDL Expanding and Transforming Its Offering in Clinical Trials | • The acquisition illustrates the Group's strategy to strengthen its position in the entire value chain of diagnosis and stresses the pivotal role of clinical trial services. • It offers Viroclinics-DDL a broader range of capabilities in it... |
| Sep 15, 2021 | Turning Precision Medicine into Action in Immuno-Oncology, Upcoming Webinar Hosted by Xtalks | In the path to precision medicines, the use of molecular markers and protein biomarkers in both early- and late-stage immuno-oncology trials has become an increasingly important way to optimize patient selection, perform safety monitoring a... |
| Apr 22, 2021 | Conducting Clinical Trials During COVID-19: Lessons for the Next Pandemic, Upcoming Webinar Hosted by Xtalks | We are still working on predictive biomarker testing to identify people who are at the most risk of developing severe symptoms, epidemiological, vaccine and genetic studies. TORONTO (PRWEB) April 22, 2021 The coronavirus is not the first in... |
| Mar 31, 2021 | Leveraging Medical Laboratory Data for Patient Recruitment, Upcoming Webinar Hosted by Xtalks | Agility, adaptability and digitization need to be the new keywords for more manageable and secure development. TORONTO (PRWEB) March 31, 2021 Connecting real-world laboratory data from clinical sites and digitalizing patient data — the powe... |
Reviews 0
FAQ about Cerba Research
When was Cerba Research founded?
Cerba Research was founded in 1984.
What has the press written about Cerba Research?
Parsers VC has collected 9 articles mentioning Cerba Research, among them “Element Biosciences: Over $277 Million In Series D Raised For Democratizing Access To Advanced Biological Tools” (Jul 23, 2024) and “Advancing CAR T-Cell Therapies with Clinical Trial Customization, Upcoming Webinar Hosted by Xtalks” (Mar 25, 2024).
Is Cerba Research still active?
Yes, Cerba Research is active; its latest activity on Parsers VC dates from Jul 25, 2024.